Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Shuttleworth

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
The EMBO Journal|August 1, 1993
The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologuesD Fesquet, J C Labbé, J Derancourt, et al.
Current Medicinal Chemistry|June 9, 2011
Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitorsS J Shuttleworth, F A Silva, A R L Cecil, et al.
Transplantation|May 26, 2016
Inhibition of Histone Deacetylase 6 Reveals a Potent Immunosuppressant Effect in Models of TransplantationJonathan D Ellis, Desley A H Neil, Nick G Inston, et al.
Bioorganic & Medicinal Chemistry|January 11, 2011
Preparation and evaluation of trisubstituted pyrimidines as phosphatidylinositol 3-kinase inhibitors. 3-Hydroxyphenol analogues and bioisosteric replacementsJonathan M Large, Jane E Torr, Florence I Raynaud, et al.
Stem Cells (Dayton, Ohio)|June 23, 2007
Characterization, cryopreservation, and ablation of spermatogonial stem cells in adult rhesus macaquesBrian P Hermann, Meena Sukhwani, Chih-Cheng Lin, et al.
Bioorganic & Medicinal Chemistry Letters|January 6, 2012
AMG 837: a potent, orally bioavailable GPR40 agonistJonathan B Houze, Liusheng Zhu, Ying Sun, et al.
Journal of Medicinal Chemistry|August 30, 2008
The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer Adrian J Folkes, Khatereh Ahmadi, Wendy K Alderton, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
The EMBO Journal|August 1, 1993
The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologuesD Fesquet, J C Labbé, J Derancourt, et al.
Current Medicinal Chemistry|June 9, 2011
Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitorsS J Shuttleworth, F A Silva, A R L Cecil, et al.
Transplantation|May 26, 2016
Inhibition of Histone Deacetylase 6 Reveals a Potent Immunosuppressant Effect in Models of TransplantationJonathan D Ellis, Desley A H Neil, Nick G Inston, et al.
Bioorganic & Medicinal Chemistry|January 11, 2011
Preparation and evaluation of trisubstituted pyrimidines as phosphatidylinositol 3-kinase inhibitors. 3-Hydroxyphenol analogues and bioisosteric replacementsJonathan M Large, Jane E Torr, Florence I Raynaud, et al.
Stem Cells (Dayton, Ohio)|June 23, 2007
Characterization, cryopreservation, and ablation of spermatogonial stem cells in adult rhesus macaquesBrian P Hermann, Meena Sukhwani, Chih-Cheng Lin, et al.
Bioorganic & Medicinal Chemistry Letters|January 6, 2012
AMG 837: a potent, orally bioavailable GPR40 agonistJonathan B Houze, Liusheng Zhu, Ying Sun, et al.
Journal of Medicinal Chemistry|August 30, 2008
The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer Adrian J Folkes, Khatereh Ahmadi, Wendy K Alderton, et al.
Pageof 14